suMMARY A double-blind study was made of men who had had a myocardial infarction at least one year previously, and who were being treated with propranolol, atenolol, or placebo. They were compared with age-and sex-matched control subjects. Under resting conditions, there were no differences between the systemic arterial blood pressures, forearm blood flows, or heart rates of the control subjects and the post-infarction patients treated with placebo. The patients, however, showed signs of reduced sympathetic effects on the cardiovascular system when their reflex responses to the Valsalva manoeuvre, lower body negative pressure, and performance of a mental task were assessed. Long-term treatment with propranolol or atenolol had little effect on resting systemic arterial blood pressure or forearm blood flow, but caused a significant reduction in resting heart rate. Differences in the reflex responses of these patients and those on placebo were attributable to the effects of the beta-adrenoceptor antagonists on resting heart rate. These results indicate that post-infarction patients do not have signs of overactivity of autonomic nervous control of the cardiovascular system. Furthermore, long-term treatnent of such patients with beta-adrenoceptor antagonists does not impair cardiovascular reflexes.
Patients with an acute myocardial infarction frequently have physical signs suggestive of excessive autonomic nervous system activity. A sinus tachycardia and systemic hypertension may indicate overactivity of the sympathetic nervous system, while sinus bradycardia may indicate overactivity of the parasympathetic system.' It has been suggested that such autonomic "imbalance" may contribute to the high mortality of acute infarction.1 On the other hand, it is possible that activation of the sympathetic system is a desirable reflex response that tends to improve cardiac performance, while parasympathetic-mediated bradycardia may have the useful function of reducing myocardial oxygen demand.
Reflexes mediated through the autonomic system are difficult to investigate when patients are ill, but within the first few days after infarction it has been
shown that the bradycardia induced by face immersion (the "diving reflex") is increased, possibly indicating sensitisation of cardiac paraReceived for publication 8 and little is known about other cardiovascular reflex mechanisms in patients who have suffered a myocardial infarction.3 4 The value of long-term treatment with betaadrenoceptor antagonists after a myocardial infarction is still not clear. Though they have been claimed to reduce mortality, the mechanism by which they do so is unknown. They do not appear to have much antiarrhythmic effect5 but one possibility is that they modify cardiovascular reflexes in a way that protects the heart from undesirable autonomic nervous influence.
We have therefore compared cardiovascular reflexes in a group of survivors of myocardial infarction (who were either untreated, or who had received beta-adrenoceptor antagonists for at least one year) with those of a matched group of healthy subjects. Subjects and methods Twenty-four men aged less than 60 years, who had had a proven myocardial infarction at least 12 months previously, were studied. None suffered from angina or had symptoms or signs of heart failure; all had returned to their preinfarction level of activity. All were taking part in a trial comparing propranolol (a non-selective beta-adrenoceptor antagonist6), atenolol (a cardioselective betaadrenoceptor antagonist6), or placebo in postinfarction patients. In that trial, the results of which will be described elsewhere (Wilcox et al., in preparation), treatment began immediately after admission to a coronary care unit; thus the patients described in the present study had received either a beta-adrenoceptor antagonist or placebo for at least 12 months. No patient was receiving any other treatment. The amounts of beta-adrenoceptor antagonists administered (propranolol 80 mg bd and atenolol 50 mg bd) were thought to be equipotent in terms of heart rate and blood pressure reduction,6 and were considered to be the maximum doses likely to be acceptable to the patients.
The ratios of anterior to inferior infarctions in the three treatment groups were: propranolol 5 
Results
The details of the patients and control subjects are shown in Table 1 . Their supine resting blood pressures, heart rates, and heart rate variability during deep breathing are shown in Table 2 . The resting heart rates in the patients treated with propranolol or atenolol were significantly lower than those ofthe controls or placebo-treated patients, but there were no other significant differences.
COMPARISON OF CONTROL SUBJECTS WITH PLACEBO-TREATED POST-INFARCTION PATIENTS
During the Valsalva manoeuvre, the control subjects showed a significantly (p <0-05) greater tachycardia than the patients, and after the manoeuvre their overshoot in systolic blood pressure and the accompanying bradycardia were more pronounced (p < 0 05) (Fig. 1) . The bradycardia relative to the pressure overshoot was similar, however, in control subjects and patients. The Valsalva manoeuvre elicited changes in diastolic blood pressure and forearm vascular resistance which were not significantly different in the control subjects and patients (Fig. 1) .
On exposure to lower body negative pressure the fall in systolic pressure was less and the increase in forearm vascular resistance was greater in the control subjects, but this difference did not achieve significance, probably because of the large intraindividual variation (Table 3 ). The post-infarction patients, however, showed a smaller rise in heart rate (p <005, Table 3 ), and examination of RR interval and systolic blood pressure during lower body negative pressure showed that there was a significant (p < 0 05) difference between the slopes for this relation in the control subjects and the patients (Fig. 2) .
The pressor response to mental stress was similar in control subjects and placebo-treated, postinfarction patients (Table 4) , though the tachycardia was less (p < 005) in the latter group (Table 4) . During the Valsalva manoeuvre the maximum heart rates seen in the propranolol-treated or atenolol-treated patients were significantly (p < 0 05) lower than in the placebo-treated patients, but this was entirely attributable to the differences in the resting state (Fig. 1) , as were the differences in maximum systolic pressures seen after the manoeuvre. While the bradycardia after the manoeuvre was less (p <0 05) in the propranololor atenolol-treated patients, the bradycardia relative to the pressure overshoot was similar in all groups of patients. The changes in diastolic blood pressure and forearm vascular resistance elicited by the Valsalva manoeuvre were not different in the three groups of patients (Fig. 1) . The patterns of cardiovascular response to lower body negative pressure were similar in all three groups of patients (Table 3) , and the slopes for the regressions of RR interval on systolic blood pressure during lower body negative pressure showed no significant differences between the placebo-treated and beta-adrenoceptor antagonisttreated patients (Fig. 2) .
The cardiovascular responses to mental stress were similar in all three groups of patients (Table 4) The patients showed less tachycardia during the Valsalva manoeuvre,1' during lower body negative pressure,12 and during performance of a mental task.13 In the patients there was also a smaller overshoot of blood pressure after the Valsalva manoeuvre, and there was a relatively greater fall in blood pressure and a smaller increase in peripheral vascular resistance in response to lower body negative pressure. All these changes are consistent with reduced sympathetic efferent effects, but as the pressor response to mental stress was intact, some sympathetic efferent path-ways must have been normal in these patients. It is possible that the post-infarction patients had some abnormality on the afferent side of the reflex arc, but it is difficult to envisage a single abnormality that would account for the responses seen. It is, of course, by no means certain that the differences in sympathetic responses that we detected between the control subjects and the post-infarction patients were the results of the previous infarction. For example, it is quite possible that they were the result of different levels of habitual activity in the two groups.
Long-term treatment with either a cardioselective or a nonselective beta-adrenoceptor antagonist had remarkably little effect on the results of our tests of autonomic function. Patients treated with propranolol or atenolol had significantly lower resting heart rates than patients treated with a placebo, a finding consistent with the known effects of these drugs. The reduction in the overshoot of systolic arterial pressure after the Valsalva manoeuvre in these patients could be attributed to the effect of the drugs on cardiac output, as has been seen in subjects treated acutely.'4 Performance of a mental task, however, elicited changes in heart rate and systolic arterial pressure which, as percentages of the resting values, were similar to those seen in the placebo-treated patients. This may indicate that long-term treatment with betaadrenoceptor antagonists does not attenuate the cardiovascular effects of cortical activation.
Our findings show that several months after a myocardial infarction the parasympathetic innervation of the heart functions normally, though the sympathetic innervation of the cardiovascular system has, for some reason, lesser effects than in normal subjects. There is nothing to suggest that patients who have had an infarction have overactive autonomic nervous systems that might prejudice their response to an infarction. The "autonomic imbalance" seen in acute myocardial infarction is therefore likely to be a result and not a cause of infarction.
It seems that long-term treatment with betaadrenoceptor antagonrists does not have a distinct effect on cardiovascular reflexes in post-infarction patients.
